Welcome!

News Feed Item

Injectable Drug Delivery - Advances in Drug Delivery, Injection Devices and Technology (Conference, London)

DUBLIN, Mar. 20, 2014 /PRNewswire/ --

Research and Markets

(

http://www.researchandmarkets.com/research/sq2qm5/injectable_drug

) has announced the addition of the

"Injectable Drug Delivery - Advances in Drug Delivery, Injection Devices and Technology (Conference, London)"

conference to their offering.



(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The Injectable Drug Delivery Conference will be held on the 26th & 27th March 2014 at Le Meridien Hotel, Piccadilly, London



KEY TOPICS TO INCLUDE:


- Market trends


- Human factors and useability


- Fluid dynamics - modelling the realities of injection performance


- Delivery of high viscosity drugs


- Case study presentation on devices in development


- Latest self injection trends


- Development of a parenteral device


- Delivery of high volumes


- Compliance modelling and parenteral drug delivery


- The insulet drug delivery system



DATES:



26 & 27 March 2014



TIMES:



Day One: 26 March 2013


Start times: 9.30 Finish 17.45



Drinks Reception Followed by Dinner 19.30



Day Two: 27 March 2013


Start times: 9.00 Finish 16.15



VENUE FOR CONFERENCE AND DINNER:



Le Meridien Hotel, Piccadilly, London



NOTE: Please note that there is a Pre-conference seminar on 25th March on 'Prefilled Syringes - Advances in Manufacture' and also a Post Conference Workshop on 28th March on 'Human Factors and Usability Engineering in the development of drug delivery products'.



Events may be cancelled due to commercial or organisational reasons. In this case Research and Markets will refund all registration fees which have already been paid. Research and Markets will not refund any charges arising from the participant having to cancel or re-book transportation or accommodation which he or she has arranged



Key Topics Covered:



INJECTABLE DRUG DELIVERY DAY ONE - 26 March 2013



09.30 - Chairman's Welcome and Introduction


Dr Gregory Berman,


Head of Innovation and Technology Management Group, Sagentia, UK



09.40 - Key Note Address: Market Trends



- High concentration formulations



- Larger doses, less frequent injections


Mathias Romacker, Drug Delivery Devices and Business Development, Amgen, USA



10.20 - Human Factors and Useability



- Ethonographic research on atuoinjector use for chronic conditions



- Relationship between a disease and its therapy - emotional and functional levels



- How this affects device selection


Mathew Young, CEO, Oval Medical Technologies Ltd, UK



11.00 - Discussion followed by Coffee



11.30 - Fluid Dynamics - Modelling the Realities of Injection Performance



- Mathematical modelling enables the opportunities and challenges of a range of device types to be explored early



- The implications of such characteristics as viscosity, dose volume and injection frequency are inseparable from the choice of delivery device



- Unfortunately, early consideration of the delivery device does not always take place. Opportunities can thus be lost and problems created which are costly and difficult to solve later



- Mathematical modelling techniques, applied properly, improve understanding of the issues concerned and enable better and earlier decisions to be taken



- Better informed decisions and better appreciations of the design options in turn support device designs which are better for the end user



- Early understanding of device issues supports and enables robust designs and capable manufacture



- Early understanding can shorten development timescales, in turn making earlier approval and earlier revenues possible


Andy Fry, Founder, Team Consulting, UK



12.10 - Delivery of High Viscosity Drugs



- Device formats



- Overcoming the challenges


Speaker, (invited)



12.50 - Discussion followed by Lunch



14.10 - Mixing Technologies for Reconstitution Devices



- Market Needs - Industry drivers and demands for these types of devices



- Latest mixing technologies



- Comparison of Lyophilised and Spray drying technologies



- Technical challenges with these types of devices


Tom Bailey, Managing Director, 3PInnovation, UK



14.50 - Device Case Study


Ian Anderson, Innovation Director, Bespak UK (invited)



15.30 - Discussion followed by Tea



16.10 - Latest Self Injection Trends



- General market trends



- Trends for biologics



- Trends for generics



- Pre-configured devices



- Future outlook


Mats Persson, Managing Director, SHL Group, Sweden



16.50 - Innovation in Primary Container Materials



- Trends for user requirements intended for self injection



- Material technology options and selection criteria



- Integration of Quality by Design for components



- Platform approach for lifecycle management


Tibor Hlobik, West Pharmaceutical Services



17.30 - Discussion



17.45 - End of Day One



19.30 - Drinks Reception Followed by Dinner at Le Meridien Hotel, London



INJECTABLE DRUG DELIVERY DAY TWO - 27 March 2013



09.00 - Review of Day One


Dr Gregory Berman,


Head of Innovation and Technology Management Group, Sagentia, UK



09.10 - What Does Pharma Want From its Drug Delivery Suppliers


Nick Bowman, Senior Director, Head of Devices COE, Pfizer, UK



09.50 - Pump Technology Case Study


Jonathan Rigby, President & CEO, SteadyMed Therapeutics Inc, USA, (invited)



10.30 - Discussion followed by Coffee



11.10 - Compliance Monitoring and Parenteral Drug Delivery



- Why is the industry suddenly talking about compliance and adherence monitoring (clinical trials and commercial applications)



- Advances in wireless communications enabling intelligent compliance monitoring



- The widespread availability of smart devices and their use in compliance monitoring, adherence and patient education



- Use of smartphone / smart devices apps for providing real-time information display and the potential for two way communications with the patient



- Regulatory issues associated with connected health systems and smartphone apps



- Using the cloud to store and disseminate data securely


Mark Tuckwell, Senior Consultant, Connected Health Systems,


Sagentia, UK



11.50 - Wireless Communication and Electronics for Compliance Monitoring



- Patient therapy compliance continues to be one of the biggest challenges in health systems



- 50% of all patients do not complete required treatment



- Reasons for the high rate of non-compliance



- Opportunities for medical manufacturers to offer innovative solutions



- Electronic compliance aids open interesting possibilities to remind, monitor and track patients' behavior, as well as to share vital therapy information with healthcare providers



- Key technologies that facilitate compliance, ranging from low-cost disposable electronics for dose counts and logs to a complete cloud-based system for monitoring compliance


Lior Shtram, Director, Design & Engineering, Flextronics Medical, Israel



12.30 - Discussion followed by Lunch



14.00 - Update on Regulations and Standards


Lee Leichter, President P/L Medical, USA



14.40 - The Insulet Drug Delivery System



Consists of two components


- Drug Delivery Pod


- Drug Delivery Manager



A Programmable, body worn, disposable, subcutaneous infusion pump



- Delivers up to 2ml of drug product over a three day period


- Delivery rate from 0.5 to 300 µl/hr


- Automated catheter insertion


- Waterproof (IPX8 25 feet for up to 60 minutes)



Provides the HCP and user maximum control, versatility, comfort and safety, while overcoming the numerous drawbacks of conventional infusion pump systems


Kevin Schmid, Vice President, Business Development & Advanced Technology Insulet Corporation, USA



15.20 - The Rise of the Bolus Injector



The changing needs of patients and new drugs are driving the growth of a new class of injection device: the large volume' or bolus' injector. This presentation will report the findings of a new research project run in collaboration with the Judge Business School, covering:



- The changing needs of patients and new drugs



- Could autoinjectors and infusion pumps meet the needs?



- Bolus injectors: a new class of injection device



- Example devices



- What to expect from the draft standard ISO 11608-6' on bolus injectors.


Tom Oakley, Director of Drug Delivery Device Development, Springboard, UK



16.00 - Discussion and Chairman's Closing Remarks



16.15 - End of Conference and Tea




For more information visit

http://www.researchandmarkets.com/research/sq2qm5/injectable_drug



Media Contact:

Laura Wood , +353-1-481-1716, [email protected]


SOURCE Research and Markets

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
"Splunk basically takes machine data and we make it usable, valuable and accessible for everyone. The way that plays in DevOps is - we need to make data-driven decisions to delivering applications," explained Andi Mann, Chief Technology Advocate at Splunk and @DevOpsSummit Conference Chair, in this SYS-CON.tv interview at @DevOpsSummit at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
Security, data privacy, reliability, and regulatory compliance are critical factors when evaluating whether to move business applications from in-house, client-hosted environments to a cloud platform. Quality assurance plays a vital role in ensuring that the appropriate level of risk assessment, verification, and validation takes place to ensure business continuity during the migration to a new cloud platform.
Fact is, enterprises have significant legacy voice infrastructure that’s costly to replace with pure IP solutions. How can we bring this analog infrastructure into our shiny new cloud applications? There are proven methods to bind both legacy voice applications and traditional PSTN audio into cloud-based applications and services at a carrier scale. Some of the most successful implementations leverage WebRTC, WebSockets, SIP and other open source technologies. In his session at @ThingsExpo, Da...
In his session at @DevOpsSummit at 19th Cloud Expo, Robert Doyle, lead architect at eCube Systems, will examine the issues and need for an agile infrastructure and show the advantages of capturing developer knowledge in an exportable file for migration into production. He will introduce the use of NXTmonitor, a next-generation DevOps tool that captures application environments, dependencies and start/stop procedures in a portable configuration file with an easy-to-use GUI. In addition to captur...
Who are you? How do you introduce yourself? Do you use a name, or do you greet a friend by the last four digits of his social security number? Assuming you don’t, why are we content to associate our identity with 10 random digits assigned by our phone company? Identity is an issue that affects everyone, but as individuals we don’t spend a lot of time thinking about it. In his session at @ThingsExpo, Ben Klang, Founder & President of Mojo Lingo, discussed the impact of technology on identity. Sho...
A critical component of any IoT project is what to do with all the data being generated. This data needs to be captured, processed, structured, and stored in a way to facilitate different kinds of queries. Traditional data warehouse and analytical systems are mature technologies that can be used to handle certain kinds of queries, but they are not always well suited to many problems, particularly when there is a need for real-time insights.
In his session at DevOps Summit, Tapabrata Pal, Director of Enterprise Architecture at Capital One, will tell a story about how Capital One has embraced Agile and DevOps Security practices across the Enterprise – driven by Enterprise Architecture; bringing in Development, Operations and Information Security organizations together. Capital Ones DevOpsSec practice is based upon three "pillars" – Shift-Left, Automate Everything, Dashboard Everything. Within about three years, from 100% waterfall, C...
You think you know what’s in your data. But do you? Most organizations are now aware of the business intelligence represented by their data. Data science stands to take this to a level you never thought of – literally. The techniques of data science, when used with the capabilities of Big Data technologies, can make connections you had not yet imagined, helping you discover new insights and ask new questions of your data. In his session at @ThingsExpo, Sarbjit Sarkaria, data science team lead ...
WebRTC has had a real tough three or four years, and so have those working with it. Only a few short years ago, the development world were excited about WebRTC and proclaiming how awesome it was. You might have played with the technology a couple of years ago, only to find the extra infrastructure requirements were painful to implement and poorly documented. This probably left a bitter taste in your mouth, especially when things went wrong.
"We provide DevOps solutions. We also partner with some key players in the DevOps space and we use the technology that we partner with to engineer custom solutions for different organizations," stated Himanshu Chhetri, CTO of Addteq, in this SYS-CON.tv interview at DevOps at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
DevOps tends to focus on the relationship between Dev and Ops, putting an emphasis on the ops and application infrastructure. But that’s changing with microservices architectures. In her session at DevOps Summit, Lori MacVittie, Evangelist for F5 Networks, will focus on how microservices are changing the underlying architectures needed to scale, secure and deliver applications based on highly distributed (micro) services and why that means an expansion into “the network” for DevOps.
WebRTC is bringing significant change to the communications landscape that will bridge the worlds of web and telephony, making the Internet the new standard for communications. Cloud9 took the road less traveled and used WebRTC to create a downloadable enterprise-grade communications platform that is changing the communication dynamic in the financial sector. In his session at @ThingsExpo, Leo Papadopoulos, CTO of Cloud9, discussed the importance of WebRTC and how it enables companies to focus o...
Providing secure, mobile access to sensitive data sets is a critical element in realizing the full potential of cloud computing. However, large data caches remain inaccessible to edge devices for reasons of security, size, format or limited viewing capabilities. Medical imaging, computer aided design and seismic interpretation are just a few examples of industries facing this challenge. Rather than fighting for incremental gains by pulling these datasets to edge devices, we need to embrace the i...
Web Real-Time Communication APIs have quickly revolutionized what browsers are capable of. In addition to video and audio streams, we can now bi-directionally send arbitrary data over WebRTC's PeerConnection Data Channels. With the advent of Progressive Web Apps and new hardware APIs such as WebBluetooh and WebUSB, we can finally enable users to stitch together the Internet of Things directly from their browsers while communicating privately and securely in a decentralized way.
All organizations that did not originate this moment have a pre-existing culture as well as legacy technology and processes that can be more or less amenable to DevOps implementation. That organizational culture is influenced by the personalities and management styles of Executive Management, the wider culture in which the organization is situated, and the personalities of key team members at all levels of the organization. This culture and entrenched interests usually throw a wrench in the work...